Healthtech Startup Dectrocel Raises Four Crore Rupees
Lucknow-based healthtech startup Dectrocel, co-founded in 2020, Ankit Shukla, Saumya Shukla, and Nikhil Mishra, has raised four crore rupees in a funding round led IAN Group-powered BioAngels, with participation from PadUp Ventures and Vinners. Key investors from IAN include Nitin Zamre, Samir Kalia, and Mitesh Shah.
The funding will be used to scale Dectrocel’s commercial operations across India, enhance its self-learning foundational multimodal AI technology, expand into international markets, and accelerate the launch of upcoming AI diagnostic tools for CT, MRI, PET-CT, and HPB disease modules.
Also Read- FlexifyMe Raises Twenty Crore Rupees in Pre-Series A Funding
Dectrocel develops AI-powered diagnostic solutions for respiratory and hepato-pancreatico-biliary (HPB) diseases. Its flagship product, DecXpert, is one of only three AI-based diagnostic tools approved for clinical use in India CDSCO, delivering chest X-ray and CT-scan interpretations up to ten times faster with 98% accuracy.
The startup addresses India’s acute shortage of radiologists especially in tier-2 and smaller cities, where diagnostic delays of seven to ten days and error rates of 25-40% are common.
“We’re not just building AI diagnostic tools we’re saving lives by ensuring that patients in tier-3 cities receive the same quality interpretations as those in metro hospitals. Our 40.1% improvement in missed case detection, validated in Nature Scientific, proves that AI can be a great equalizer in healthcare access,” said Ankit Shukla, Founder & Technical Director, Dectrocel.
The company plans to expand DecXpert across OEM partner networks, capture a share of India’s one-thousand-crore digital X-ray market, establish a presence in Southeast Asia, and diversify its product offerings with new diagnostic modules and enhanced AI capabilities for broader pathology detection.
